Episode 220: Post-ROSC Care

Maximize your commute with the new Core EM Modular CME Course, featuring the most essential content distilled from our top-rated podcast episodes. This course offers 12 audio-based modules packed with pearls! Information and link below. 

Course Highlights:

• Credit: 12.5 AMA PRA Category 1 Credits™
• Curriculum: Comprehensive coverage of Core Emergency Medicine,  with 12 modules spanning from Critical Care to Pediatrics.
• Cost:
  • Free for NYU Learners
  • $250 for Non-NYU Learners

• High-Risk Period: Rearrest rates reach 30% within the first minutes post-ROSC.
  
• Shock Incidence: Two-thirds of patients develop profound hypotension/shock as initial resuscitative efforts subside.
  
• Catecholamine Washout: Super-physiologic “code-dose” epinephrine (1mg IV) typically wears off within ~3 minutes post-ROSC, leading to predictable hemodynamic collapse.
  
• Secondary Injuries: Evaluate for “CPR-induced trauma” (blunt thoracic trauma, rib fractures, pneumothorax, liver/splenic lacerations).
  

• Vascular Access:
  • Transition rapidly from IO to reliable IV access within 1–2 minutes.
    
  • Prioritize Intraosseous (IO) placement within 5 minutes if IV attempts fail; intra-arrest data suggests no significant difference in early outcomes.
    
• Vasoactive “Bridge”:
  • Maintain a “bolus-dose” pressor at the bedside for immediate push-dose titration.
    
  • Options: Phenylephrine, dilute Epinephrine, or dilute Norepinephrine (titrated to effect rather than rigid dosing).
    
• Physician-Specific Task: Arterial Line:
  • Goal: Placement within 5 minutes of ROSC.
    
  • Preferred Site: Femoral (by landmarks/blind if necessary) for speed; should be a <2-minute procedure.
    
  • Utility: Immediate detection of rearrest and beat-to-beat titration of vasopressors.
    

• ACS Shift: Acute Coronary Syndrome (ACS) is the cause in only 6–10% of resuscitated survivors (lower than historical estimates).
  
• Common Etiologies:
• Respiratory: COPD, pneumonia, mucus plugging.
  
  • Cardiac: Arrhythmia (cardiomyopathy/scar), RV failure (PE), or LV failure.
    
  • Neurological: Intracranial hemorrhage (SAH/ICH), status epilepticus (4–5%).
    
  • Metabolic: Dialysis-related disarray/hyperkalemia.
    
  • Toxicology: Overdose accounts for ~10% of cases in urban centers.
    

• “Rainbow Labs”: Comprehensive panel including toxicology and serial biomarkers.
  
• Pan-Scan Protocol:
  • Components: CT/CTA Head/Neck, Contrast CT Chest/Abdomen/Pelvis.
    
  • Diagnostic Yield: 50% for clinically significant findings (causes or consequences of arrest).
    
  • Contrast Risk: Negligible (1–2% increase in AKI risk) compared to the high diagnostic utility.
    
• Avoid Anchoring: Do not assume ischemic EKG changes are the cause; they are frequently a consequence of the global arrest-induced ischemia.
  

• Autoregulation Shift: In acute brain injury/post-arrest, the lower limit of cerebral autoregulation shifts right, often requiring MAPs of 110–120 mmHg for adequate perfusion.
• Clinical Target: Aim for MAP >80 mmHg.
  
• The BOX Trial Nuance: While the BOX trial showed no difference between MAP 63 vs. 77, its cohort (Denmark) had exceptionally high survival rates (70% back to work) and short response times, which may not generalize to North American populations with lower shockable rhythm incidence.
  
• Permissive Hypertension: If the patient is “self-driving” to higher pressures, do not aggressively lower them, as this may be a physiologic demand for cerebral blood flow.
  

• PaCO2 Management:
  • Target: High-normal to slightly hypercarbic (45–55 mmHg).
    
  • Rationale: Avoid accidental hyperventilation (PaCO2 <30), which can cut cerebral blood flow by 50%.
    
• PaO2 Management: Maintain normoxia; avoid extreme hyperoxia, though trial data (BOX trial) suggests small variances (70 vs 90 mmHg) are likely neutral.
  

• Anoxic Depolarization: Occurs within ~2 minutes of pulselessness as ATP-dependent ion pumps fail.
  
• Clinical Pitfall: Early neurological exams (absent pupils, no motor response) are unreliable in the first hours as they reflect global neuronal “stunning” rather than definitive permanent injury.
  
• Time Horizon: Meaningful recovery is measured in days/weeks, not minutes/hours.
  

• Presence: Bring family to the bedside immediately, including during procedures or continued resuscitation.
  
• Psychological Impact: Significantly reduces PTSD, anxiety, and depression in survivors’ families.
  
• Prognostic Honesty: Explicitly state “I don’t know” regarding etiology and outcome.
  
• Framing: Define “No News” as the best possible early outcome (preventing rearrest and stabilization).